MedTrace Logo

Twelve Month Follow-Up of CP0108

NCT02209012 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 206

Last updated 2016-09-23

No results posted yet for this study

Summary

The purpose of this study is to determine the long-term safety and efficacy of Levulan PDT in subjects with multiple actinic keratosis of the upper extremities who received treatment as part of the DUSA CP0108 study.

Conditions

  • Actinic Keratosis

Interventions

DRUG

Aminolevulinic Acid (ALA)

Levulan PDT given in CP0108

DRUG

Topical Solution Vehicle

Vehicle PDT given in CP0108

DEVICE

BLU-U Blue Light Photodynamic Therapy Illuminator

PDT given in CP0108

Sponsors & Collaborators

  • DUSA Pharmaceuticals, Inc.

    lead INDUSTRY

Principal Investigators

  • Stuart Marcus, MD, PhD · DUSA Pharmaceuticals, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2016-02-29
Completion
2016-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02209012 on ClinicalTrials.gov